Physician

Martin A Boscarino, M.D.

According to 2025 Medicare claims, Martin Boscarino, M.D. (NPI: 1902850522) practices ophthalmology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1285675660; TIN: 112498332) and primary practice location at 14221-7051.

Boscarino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 800 traditional Medicare patients, billed 20,670 HCPCS/CPT codes, and received $1,653,137 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 766 prescription claims across 219 beneficiaries totaling $35,777 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $98. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,229,482 to $1,653,137. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $34,612 and ending at $35,777. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$889K$1.8M2015 Medicare payment: $1,229,482 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,205,882 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,020,515 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $990,358 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $910,359 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $888,987 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,321,148 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,778,287 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,622,165 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,653,137 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155978,608$1,229,482
20165967,772$1,205,882
20174716,131$1,020,515
20184555,661$990,358
20194595,509$910,359
20204505,168$888,987
20217617,675$1,321,148
20228459,919$1,778,287
202370014,707$1,622,165
202480020,670$1,653,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $34,612 (USD; Tot_Drug_Cst)2016 Drug cost: $27,176 (USD; Tot_Drug_Cst)2017 Drug cost: $24,720 (USD; Tot_Drug_Cst)2018 Drug cost: $29,787 (USD; Tot_Drug_Cst)2019 Drug cost: $37,621 (USD; Tot_Drug_Cst)2020 Drug cost: $29,907 (USD; Tot_Drug_Cst)2021 Drug cost: $31,391 (USD; Tot_Drug_Cst)2022 Drug cost: $45,958 (USD; Tot_Drug_Cst)2023 Drug cost: $39,669 (USD; Tot_Drug_Cst)2024 Drug cost: $35,777 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128378$34,612
2016121361$27,176
2017114346$24,720
2018113358$29,787
2019133436$37,621
2020137379$29,907
2021196516$31,391
2022194676$45,958
2023195785$39,669
2024219766$35,777

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2821,442$91
92014Established patient complete exam of visual system632933$88
92012Established patient problem focused exam of visual system3291,211$64
92134Imaging of retina5931,891$30
92250Photography of the retina295322$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate35210,604$12,216
IlevroNepafenac12228$4,474
DifluprednateDifluprednate21528$2,336
Ketorolac TromethamineKetorolac Tromethamine1415,477$2,312
MoxifloxacinMoxifloxacin Hcl891,707$2,158

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$98Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Martin A. Boscarino, M.D.?

Tedicare shows public-source Medicare data for Martin A. Boscarino, M.D. (NPI 1902850522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Martin A. Boscarino, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Martin A. Boscarino, M.D.?

Martin A. Boscarino, M.D. is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1285675660) in the available physician profile data.

Does Martin A. Boscarino, M.D. have Open Payments data?

Martin A. Boscarino, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.